Coronavirus disease 2019 treatment: a review of early and emerging options

EK McCreary, JM Pogue - Open forum infectious diseases, 2020 - academic.oup.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus
disease 2019 (COVID-19), has spread across the globe resulting in a pandemic. At the time …

COVID-19 outbreak and emerging management through pharmaceutical therapeutic strategy

MH Rahman, R Akter, T Behl… - Current …, 2020 - ingentaconnect.com
The latest SARS COV2 coronavirus contributes to a pandemic of millions of COVID-19. As
there is no defensive immunity in humans and a virus can overcome inborn immune …

[HTML][HTML] The therapeutic effect and safety of the drugs for COVID-19: a systematic review and meta-analysis

R Qiu, J Li, Y Xiao, Z Gao, Y Weng, Q Zhang, C Wang… - Medicine, 2021 - journals.lww.com
Background: Coronavirus disease 2019 (COVID-19) has spread almost all regions of the
world and caused great loss to the whole body of mankind. Thus, numerous clinical trials …

A comprehensive updated review on SARS‐CoV‐2 and COVID‐19

YR Ren, A Golding, A Sorbello, P Ji… - The Journal of …, 2020 - Wiley Online Library
This literature review aims to provide a comprehensive current summary of the
pathogenesis, clinical features, disease course, host immune responses, and current …

Medical treatment options for COVID-19

L Delang, J Neyts - European Heart Journal: Acute …, 2020 - journals.sagepub.com
Therapeutic options for coronavirus disease 2019 are desperately needed to respond to the
ongoing severe acute respiratory syndrome coronavirus 2 pandemic. Both antiviral drugs …

Safety and Efficacy of antiviral drugs against covid-19 infection: an updated systemic review

AMR Al-juhaishi, ND Aziz - Medical and Pharmaceutical Journal, 2022 - pharmacoj.com
SARS-CoV-2 infection is an acute pneumonia attack caused by a largely-infectious, recently
elicited, and murdered virus with global public health issues and economic problems. Many …

[HTML][HTML] Coronavirus disease 2019 (COVID-19): latest developments in potential treatments

KL Hon, KKY Leung, AKC Leung, SY Qian… - Drugs in …, 2020 - ncbi.nlm.nih.gov
Many viral respiratory infections can cause severe acute respiratory symptoms leading to
mortality and morbidity. In the spring of 2003, the severe acute respiratory syndrome (SARS) …

[HTML][HTML] Pharmacologicaltreatment of COVID-19: lights and shadows

F Menzella, M Biava, C Barbieri, F Livrieri… - Drugs in …, 2020 - ncbi.nlm.nih.gov
At the end of December 2019, a novel coronavirus, the severe acute respiratory syndrome
coronavirus 2, caused an outbreak of pneumonia spreading from Wuhan, Hubei province, to …

Progress in the research and development of anti-COVID-19 drugs

L Huang, Y Chen, J Xiao, W Luo, F Li, Y Wang… - Frontiers in public …, 2020 - frontiersin.org
The outbreaks of COVID-19 due to SARS-CoV-2 has caused serious physical and
psychological damage to global human health. COVID-19 spread rapidly around the world …

Is there any potential management against COVID-19? A systematic review and meta-analysis

H Talaie, SM Hosseini, M Nazari, Y Fakhri… - DARU Journal of …, 2020 - Springer
Purpose A recent survey has shown that the COVID-19 pandemic has culminated in
dramatical and critical treatment particularly in acute infected patients. In fact, this systematic …